Title : Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.

Pub. Date : 2007 Sep

PMID : 17996658






5 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens
2 Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens
3 After controlling for covariates, rosuvastatin-treated patients had a 35.8% decrease in LDL-C from baseline, which was significantly greater compared with patients in the atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin (29.3%, 21.9%, 22.5%, 22.0%, and 24.9%, respectively; P < 0.05) groups. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens
4 CONCLUSION: In this elderly patient population, rosuvastatin was a more effective treatment for reducing LDL-C levels and attaining NCEP ATP III LDL-C goals than the other statins. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens
5 CONCLUSION: In this elderly patient population, rosuvastatin was a more effective treatment for reducing LDL-C levels and attaining NCEP ATP III LDL-C goals than the other statins. Rosuvastatin Calcium component of oligomeric golgi complex 2 Homo sapiens